Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Molecular Reproduction and Development|November 19, 1997
Cryopreservation of mouse embryos affects later embryonic development possibly through reduced expression of the glucose transporter GLUT1H Uechi, O Tsutsumi, Y Morita, et al.Human Reproduction (Oxford, England)|November 5, 1999
Comparison of the effects of controlled-rate cryopreservation and vitrification on 2-cell mouse embryos and their subsequent developmentH Uechi, O Tsutsumi, Y Morita, et al.Research in Veterinary Science|July 1, 1997
The variation in excretory urinary glycyl-prolyl dipeptidyl aminopeptidase in dogsM Uechi, H Uechi, T Nakayama, et al.The Journal of Veterinary Medical Science|October 31, 1998
The circadian variation of urinary N-acetyl-beta-D-glucosaminidase and gamma-glutamyl transpeptidase in clinically healthy catsM Uechi, H Uechi, T Nakayama, et al.Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|September 1, 1992
[Clinical study of albendazole therapy for strongyloidiasis]S Niimura, T Hirata, O Zaha, et al.Biochemical and Biophysical Research Communications|October 1, 1998
Presence of dioxins in human follicular fluid: their possible stage-specific action on the development of preimplantation mouse embryosO Tsutsumi, H Uechi, H Sone, et al.Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|October 1, 1992
[Clinical study on symptoms in patients with strongyloidiasis]O Zaha, S Niimura, N Kinjo, et al.Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|June 1, 1991
[Comparison of efficacy of powder and tablet of mebendazole in the treatment of strongyloidiasis]K Shikiya, N Kinjo, M Ikema, et al.Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|July 1, 1992
[Clinical study of eradicated and resistant patients to treatment with ivermectin for strongyloidiasis]K Shikiya, O Zaha, S Niimura, et al.Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|March 1, 1992
[Long term eradication rate of mebendazole therapy for strongyloidiasis]K Shikiya, O Zaha, S Niimura, et al.Pageof 2